Marshall Wace North America’s Alkermes ALKS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
– Sell
-30,027
Closed -$598K – 1477
2020
Q4
$598K Buy
+30,027
New +$550K ﹤0.01% 1049
2020
Q1
– Sell
-35,199
Closed -$718K – 1195
2019
Q4
$718K Sell
35,199
-54,215
-61% -$1.08M ﹤0.01% 767
2019
Q3
$1.75M Buy
+89,414
New +$1.95M 0.01% 572
2013
Q4
$539K Buy
+13,265
New +$490K 0.01% 508

Other funds holding ALKS

Marshall Wace North America's ALKS Position: Q1 2021 in Review

Marshall Wace North America sold out of Alkermes (ALKS) in Q1 2021, closing a stake of 30,027 shares — an estimated $598K sold.

Marshall Wace North America first reported a position in ALKS in Q4 2013 and held it in 4 quarters. The position peaked at $1.75M in Q3 2019. 200 funds tracked by Wall St. Rank hold ALKS as of Q1 2021.

  • Marshall Wace North America reported no remaining Alkermes position as of Q1 2021 after selling out during the quarter.
  • Marshall Wace North America sold 30,027 Alkermes shares in Q1 2021, an estimated $598K.
  • Marshall Wace North America first reported a position in Alkermes in Q4 2013 and held it in 4 quarters.
  • Marshall Wace North America's Alkermes position peaked at $1.75M in Q3 2019.
  • 200 funds tracked by Wall St. Rank held Alkermes as of Q1 2021.

Based on Marshall Wace North America's 13F filing for Q1 2021, filed 17 May 2021.